期刊文献+

酶解高效液相色谱法测定硫酸软骨素的含量 被引量:3

Determination of chondroitin sulfate content by enzymatic HPLC
下载PDF
导出
摘要 目的建立酶解高效液相色谱法测定硫酸软骨素含量的方法。方法采用硫酸软骨素ABC酶制备样品,高效液相色谱法测定含量。以Ultimate XB-NH2柱(4.6 mm×25 cm,5μm)分离样品,醋酸钠缓冲液(pH 5.6)-乙腈(950∶50)为流动相,流速1.0 mL/min,检测波长232 nm,进样量10μL,柱温30℃。结果在此色谱条件下,硫酸软骨素A、B、C三组分分离良好;硫酸软骨素浓度在300~3 000μg/mL之间与峰面积呈良好线性关系;高、中、低三个浓度平均加样回收率为102.1%,100.4%和97.5%。结论本法简便、准确、可靠,可用于硫酸软骨素的含量测定。 Purpose To establish an enzymatic HPLC method for determination of chondroitin sulfate content. Methods The sample was prepared by chondroitinase ABC and the content was determined by HPLC. The sample was separated and analyzed on a Ultimate XB-NH2 column (25 cm× 4.6 mm ,5 μm) , and a salt acetate buffer solution(pH 5.6)- acetonitrile(950:50)was used as mobile phase. The flow rate was 1.0 mL/min. The detective wavelength was 232 nm. The injection volume was 10μL. The column temperature was 30 ℃. Results The ehondroitin sulfate A, B,C three ingredient peaks could be separated each other completely. The calibration curve was linear at a range of 300-3 000 μg/mL. The average re- coveries( n = 3 ) of high, middle, low concentrations were 102. 1% , 100.4% and 97.5% respectively. Conclusion The method was simple,accurate,reliable. It can be used for the determination of content in chondroitin sulfate.
出处 《中国生化药物杂志》 CAS CSCD 北大核心 2012年第6期827-829,共3页 Chinese Journal of Biochemical Pharmaceutics
关键词 硫酸软骨素 酶解法 高效液相色谱法 含量测定 chondroitin sulfate enzymatic method HPLC determination
  • 相关文献

参考文献12

二级参考文献54

共引文献94

同被引文献84

  • 1蔡苏兰,阎浩林,何汉洲.温和气单孢菌YH311硫酸软骨素裂解酶的分离纯化与固定化[J].生物工程学报,2004,20(4):584-589. 被引量:2
  • 2熊双丽,金征宇.不同分子量硫酸软骨素的制备和抗氧化活性探讨[J].中成药,2006,28(9):1343-1346. 被引量:8
  • 3李瑞萍,黄骏雄.亲水作用色谱及其在碱性药物分析中的应用[J].化学进展,2006,18(11):1508-1513. 被引量:26
  • 4林雪松,侯立中,杨同书.硫酸软骨素裂解酶ABC的制备[J].白求恩医科大学学报,1997,23(1):104-105. 被引量:5
  • 5Bernfield M, Gotte M, Park PW, et al. Functionsof cell surface heparan sulfate proteoglycans. Annu Rev Biochem, 1999, 68(1): 729-777.
  • 6Sugahara K, Mikami T, Uyama T, et al. Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curre Opin Strut Biol, 2003, 13(5): 612-620.
  • 7Bao X, Nishimura S, Mikami T, et al. Chondroitin sulfate/dermatan sulfate hybrid chains from embryonic pig brain, which contain a higher proportion of L-iduronic acid than those from adult pig brain, exhibit neuritogenic and growth factor binding activities. J Biol Chem, 2004, 279(11): 9765-9776.
  • 8Lamari FN, Karamanos NK. Structure of chondroitin sulfate. Adv Pharmacol, 2006, 53: 33-48.
  • 9Lauder RM. Chondroitin sulphate: a complex molecule with potential impacts on a wide range of biological systems. Compl Ther Med, 2009, 17(1): 56-62.
  • 10Aich U, Shriver Z, Tharakaraman inhibition of heparinase by glycosaminoglycans: a tool to contamination. Anal Chem, K. Competitive persulfonated detect heparin 2011, 83(20):7815-7822.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部